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Background: Skeletal muscle differentiation is a multistep, complex pathway in which several important signaling
molecules are involved. Recently, microRNAs (miRNAs), endogenous non-coding small RNAs that regulate mRNAs,
have been proposed to be involved in skeletal muscle differentiation. In this study, we identified skeletal muscle
differentiation-associated miRNAs by comparing miRNA expression profiles between C2C12 cells and Wnt4 over-expressing
C2C12 cells (W4-08), which can spontaneously differentiate into myotubes.
Results: We identified miR-206, miR-133a, and miR-133b as up-regulated miRNAs and miR-487b, miR-3963 and miR-6412 as
down-regulated miRNAs in differentiating cells. We focused on the down-regulated miRNAs because their functions were
largely unknown. Transfection of mimics of these miRNAs into C2C12 cells resulted in significantly reduced expression of
myogenic differentiation markers, including troponin T and myosin heavy chain fast type and slow type, but did not affect
the expression of the myogenic transcription factors, MyoD and myogenin.
Conclusions: These miRNAs were characterized as new myogenic differentiation-associated miRNAs which may delay late
myogenic differentiation or maturation.
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Skeletal muscle development is complex, involving several
signaling pathways. Skeletal muscles are formed from so-
mites, which are derived from paraxial mesoderm. So-
mites form initially as somitomeres, and after the
epithelization process, they form mesenchymal sclerotome
and dermomyotome. Mesodermal cells are selected to
form myoblasts and subsequently differentiate into myo-
tubes [1]. The molecular mechanism determining myo-
genesis was recently identified. The Wnt protein plays
crucial roles in the development of skeletal muscle. In-
deed, skeletal muscle is formed from paraxial mesoderm
under the influence of signals from the neural tube and
dorsal ectoderm, including Wnt proteins and BMP4 sig-
naling, and myogenic cell fate is determined by intrinsic
factors, MyoD and Myf5 [2-5]. The diverse Wnt members* Correspondence: katase@med.kawasaki-m.ac.jp
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unless otherwise stated.function differently. For example, Wnt1 expression prefer-
entially activates Myf5, while Wnt7a-expressing cells acti-
vate MyoD, and Wnt4, Wnt5a and Wnt6 can activate
both Myf5 and MyoD [6]. Wnt1, Wnt 3a and Wnt 5a in-
duce the proliferation of satellite cells, a source of myo-
blasts [7].
Wnt4 over-expression in mouse myoblast-derived
C2C12 cells induces hypertrophy of myotubes. Wnt4
over-expression in the presumptive limb field of the chick
embryo results in up-regulation of PAX7 and MyoD, and
increased skeletal muscle mass. Wnt4 over-expression in
C2C12 cells induces an increase in fast-type myosin heavy
chain (MyHC) expression. Moreover, Wnt4 is reported to
negatively regulate myostatin [8,9]. Therefore Wnt4 is
thought to possess myogenic activity.
Previously, we generated a Wnt4-over-expressing cell
line from C2C12 cells, W4-08 [4]. C2C12 cells can differ-
entiate into myotubes under reduced mitogen conditions,
while W4-08 cells can spontaneously differentiate into
myotubes even in proliferative conditions. We investigatedThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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by comparing this Wnt4-over-expressing cell line with its
parental C2C12 cell line.
MicroRNAs (miRNAs) are small, endogenous non-
coding RNAs consisting of approximately 22 nucleo-
tides that regulate mRNA expression by binding to
complementary sequences of the mRNA leading to
cleavage or translational repression [10]. These small
single strand miRNAs target one or more mRNAs and
play important roles in cell embryogenesis, cell differen-
tiation, carcinogenesis and apoptosis [11]. Recently, in-
volvement of miRNAs in skeletal muscle differentiation
has been indicated [12].
Therefore, we searched for specific miRNAs that are
involved in myogenic differentiation, and our miRNA
microarray data demonstrated two novel miRNAs, miR-
487b, miR-3963 and miR-6412 that are specifically
down-regulated in C2C12 cells cultured in differenti-
ation medium.
Transfection of the mimics of these miRNAs resulted
in decreased expression of the myogenic markers,
troponin T and myosin heavy chain (MyHC), suggesting
delayed myogenic differentiation. Our results suggest
that miR-487b, miR-3963 and miR-6412 are novel
muscle-specific miRNAs that may function as negative
regulators of skeletal muscle differentiation.Results and discussion
miRNA microarray analysis
We compared the miRNA expression profiles of
C2C12-PR cells (C2C12 cells grown in proliferation
medium) vs. W4-08 cells (Wnt4-over-expressing C2C12
cells) cultured in proliferation medium. W4-08 cells can
differentiate into myotubes even in proliferative condi-
tions. We identified 161 miRNAs to be up-regulated, in-
cluding miR-206, miR-133b and miR-133a (by 5.84, 5.46
and 5.37 fold in log2 ratio, respectively), while only
miR-487b, miR-6412 and miR-3963 were down-
regulated by about −1.00 in log2 ratio (−1.70, −0.96 and
−0.93 fold in log2 ratio, respectively). The expression of
these up- and down-regulated miRNAs were also com-
monly altered when expression in C2C12-PR vs.
C2C12-DF cells (C2C12 cells grown in differentiation
medium) was compared; 42 miRNAs were up-regulated
with miR-206, miR-133b and miR-133a being com-
monly up-regulated (2.21, 1.68 and 1.63 fold in log2 ra-
tio, respectively), and miR-487b, miR-6412 and miR-
3963 were down-regulated (−1.98, −2.99 and −2.13 fold
in log 2 ratio, respectively). (see Gene Expression Omni-
bus (GEO) at NCBI with accession number GSE63454.)
Therefore, we focused on miR-206, miR-133a, miR-
133b, miR-487b, miR-6412 and miR-3963 as a potential
myogenic differentiation-related miRNAs, and theeffect of transfection of these miRNAs on cell differen-
tiation was assessed.The effect of miRNA transfection on C2C12 differentiation
We transfected miRNA mimics of the miRNAs which
were significantly up- or down-regulated, and effects on
cellular differentiation were determined by immuno-
cytochemistry. Transfection efficacy of miRNA mimics
was confirmed by real time RT-PCR analysis of PTK9
expression following miR-1 positive control transfection
(Additional file: 1 Figure S1). Troponin T expression
was evaluated after the transfection of the mimics
followed by 3 days incubation in differentiation condi-
tions. The troponin T expression ratio reached approxi-
mately 6% in negative controls. Transfection of miR-1
positive control, miR-206 and miR-133a resulted in a
significant increase of the troponin T-positive cell ratio,
while transfection of miR-487b, miR-3963 and miR-
6412 mimics significantly decreased troponin T expres-
sion (Figure 1).
Cellular differentiation was also assessed by determin-
ing levels of fast and slow type MyHCs. Immunocyto-
chemistry for MyHCs was performed after transfection
followed by 1 week of incubation in differentiation
medium. Transfection of miR-487b and miR-3963
mimics resulted in a significant decrease in the MyHC
(fast) positive ratio (Figure 2), while miR-1 positive con-
trol, miR-206, miR-133a, miR-133b and miR-6412 did
not affect the MyHC (fast) positive cell ratio. miR-487b,
miR-3963 and miR-6412 mimics significantly decreased
the MyHC (slow) positive cell ratio (Figure 3).miR-487b, miR-3963 and miR-6412 significantly suppress
expression of troponin T
Next, we focused on miR-487b, miR-3963 and miR-
6412 transfection, which resulted in decreased differ-
entiation. We confirmed that the expression of these
miRNAs was significantly decreased in differentiation
conditions by RT-qPCR (Additional file: 2 Figure S2).
The expression of these three miRNAs was signifi-
cantly down-regulated in C2C12 cells cultured in dif-
ferentiation medium, compared with cells cultured in
proliferation medium. The mimics of these miRNAs
were transfected in C2C12 cells. To confirm when the
reduction of troponin T expression begins, its expres-
sion was assessed on days 1, 2 and 3 after transfection.
The troponin T expression ratio increased on each day
in all groups, and transfection of miRNA mimics sup-
pressed its expression significantly (Figure 4). The sup-
pression of troponin T expression was observed from day
1 for miR-487b and miR-6412, and from day 2 for miR-
3963. Next, to address the possibility that these miRNAs
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Figure 1 Troponin T expression, 3 days after transfection and medium change. Compared with the miR negative control (NC), transfection of miR-1,
miR-206 and 133a resulted in a significantly higher troponin T positive ratio, while miR-487b, miR-3963 and miR-6412 transfectants gave a significantly
lower ratio. Scale bar 50 μm. NC: negative control.
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tors, MyoD and myogenin.
miRNA mimic transfection and MyoD and myogenin
expression in C2C12 cell
MyoD expression was assessed on day 1, 2 and 3 after
transfection. MyoD and myogenin expression was ob-
served from day 1–3 in the nucleus. A positive reaction
in the nucleus is presented as the ratio of cells showing
a positive nuclear reaction. The nuclear expression ra-
tio of MyoD showed varied scores, but there was no
significant difference among miR negative control and
miRNA mimic transfection groups (Figure 5). The
myogenin nuclear expression ratio increased on each
day, but transfection of miRNA mimics did not signifi-
cantly affect its expression pattern (Figure 6). We do not
think that MyoD and myogenin cellular localization is
altered by transfection of miRNA mimics because weconfirmed that the expression patterns of these molecules
in non-transfected C2C12 cells were similar to those of
the miRNA transfection group (data not shown).
Skeletal muscle differentiation is a multistep pathway
in which several signaling molecules are implicated. In
particular, Wnt signaling plays important roles in myo-
genic commitment and differentiation. The formation
of skeletal muscle from paraxial mesoderm is influenced
by signals from the neural tube and dorsal ectoderm, in-
cluding Wnt4 and BMP4 [4]. And in adult skeletal
muscle, several Wnt members including Wnt1, Wnt3,
Wnt5a and Wnt7a are required for proliferation and dif-
ferentiation of satellite cells during myotube turnover
[5,7]. Previously we established the W4-08 cell line,
which stably over-expresses Wnt4 and spontaneously dif-
ferentiates into myotubes even in mitogen rich medium.
Comparison of gene expression profiles between W4-08
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Figure 2 miR-487b and miR-3963 transfection down-regulated fast type MyHC. miR-1, miR-206, miR-133a, miR-133b, miR-6412 did not affect MyHC
expression. Scale bar 50 μm. NC: negative control.
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Recently, involvement of miRNAs in skeletal muscle dif-
ferentiation has been debated. For example, miR-1, miR-
206, miR-133 [13,14] are known as muscle-specific miR-
NAs. Additionally, miR-23a [15], miR-24 [16], miR-26
[17], miR-27a [18,19], miR-27b [20], miR-29 [21], miR-124
[22], miR-128a [23], miR-146b [24], miR-148a [25], miR-
155 [26], miR-181 [27], miR-199 [28], miR-186 [29], miR-
214 [30], miR-221/222 [31], miR-351 [32], miR-486 [33],
miR-489 [34], miR-499 [35] and miR-3906 [36] are re-
ported to be involved in skeletal myogenesis. miRNAs can
either inhibit or promote myogenesis, depending on their
target mRNAs.
We found that miR-206, miR-133a, miR-133b were
up-regulated, and miR-487b, miR-3963, and miR-6412
were down-regulated during myogenic differentiation.
Consistent with our previous report, transfection of
miR-206, and miR-133a resulted in significantly higher
troponin T expression. However, miR-206, 133a and133b did not affect the expression of slow type or fast
type MyHC. We used miR-1 as a positive control, which
was as assayed by the down-regulation of the PTK9 tar-
get gene (Additional file: 1 Figure S1). Transfection of
miR-1 also showed significantly higher troponin T ex-
pression because miR-1 also regulates proliferation and
differentiation of myoblast cells by targeting the tran-
scription of HDAC4 [14]. However, these miRNAs,
which were significantly up-regulated in W4-08 cells,
did not affect slow type or fast type MyHC, suggesting
that these miRNAs are not significantly associated with
the late muscle differentiation step.
In this study, we identified miR-486b, miR-3963 and
miR-6412 as novel myogenic differentiation-related miR-
NAs, the functions of which are largely unknown.
Transfection of these miRNAs resulted in reduced ex-
pression of myogenic differentiation markers, particu-
larly in the late myogenic differentiation stage. However,
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Figure 3 miR-487b, miR-3963 and miR-6412 transfection down-regulated slow type MyHC. miR-1, miR-206, miR-133a and miR-133b did not affect
MyHC expression. Scale bar 50 μm. NC: negative control.
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reports have been published on the function of miR-
3963 or miR-6412. Some reports suggested that miR-
487b is associated with several kinds of pathological
condition. miR-487b is commonly and severely down-
regulated in prostate cancer cell lines, suggesting that
miR-487b may function as a tumor suppressor that regu-
lates cell proliferation, apoptosis, migration and invasion
[37]. Furthermore, miR-487b expression is significantly
associated with disease-free survival of non-MYCN-
amplified favorable neuroblastoma [38,39]. miR-487b
also promotes epithelial-mesenchymal transition in lung
adenocarcinoma cell [40], while several other reports
imply roles of miR-487b in cellular proliferation. miR-
487b is predicted to target insulin receptor-like sub-
strate, down-regulation of which may impair skeletal
muscle growth [41,42]. Xi et al reported that miR-487b
directly targets Wnt5a [43], which is important in prolif-
eration of satellite cells in adult skeletal muscle.We also sought the target of these novel myogenic
differentiation-related miRNAs using a bioinformatics
approach. The candidate target for miR-487b varied
greatly depending on the database queried and it was
difficult to determine a commonly suggested target.
However, according to microRNASeq (https://cm.jeffer-
son.edu/rna22v1.0/), miR-487b directly targets several
molecules that are involved in skeletal muscle differenti-
ation, including Wnt3, Wnt5a, troponin T type 3 (skel-
etal, fast) (TNNT3), myosin, heavy chain 1, skeletal
muscle, adult (MYH1), myosin, heavy chain 2, skeletal
muscle, adult (MYH2), myosin, heavy chain 3, skeletal
muscle, embryonic (MYH3) and myosin, heavy chain 4,
skeletal muscle (MYH4). However, we were unable to
identify candidate targets associated with muscle differ-
entiation for miR-3963 and miR-6412.
These data indicate that these newly identified miR-
NAs may directly and/or indirectly suppress skeletal
muscle differentiation and maturation.
miR negative control miR-487b miR-3963 miR-6412
*
*p<0.05 (compared with day1 NC) 
†p<0.05, ††p<0.01 (compared with day2 NC)































Figure 4 Troponin T expression from day 1 to day 3 after transfection and medium change. Troponin T expression increased on successive days.
The miRNA mimic transfection group showed a lower troponin T expression ratio. miR-487b and miR-6412 transfection resulted in significantly
lower troponin T expression from day 1. Scale bar 50 μm. NC: negative control.
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In the present study, we identified miR-487b, miR-3963
and miR-6412 as new skeletal muscle differentiation-
associated miRNAs. Transfection of mimics of these
miRNAs resulted in reduced expression in troponin T
and MyHC, but did not affect the expression of MyoD
or myogenin. These miRNAs may delay skeletal muscle
differentiation by suppressing myotube differentiation
and maturation markers. Further investigation is war-
ranted to identify the targets of these miRNAs and the
detailed mechanism by which they inhibit skeletal
muscle maturation.
Methods
Over-expression of Wnt4 in C2C12 cells
The C2C12 cell line (a myoblast-like cell line from the
C3H mouse) was purchased from the RIKEN Bioresource
Center (Tsukuba, Japan) and maintained in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with
10% fetal bovine serum (FBS) (Nichirei, Tokyo, Japan).
Stable Wnt4 transfectants were established as previ-
ously described [4,44]. Briefly, After 12 to 24 h ofsubculture, an expression vector bearing a V5-tagged
Wnt4 cDNA (PCMV-Wnt4-V5-PPGK-blasticidin-SV40pA)
was transfected into C2C12 cells. Transfected cells were
then cultured in DMEM containing 10% FBS and blasti-
cidin (Life Technologies, Carlsbad, CA, USA). After ser-
ial passages in blasticidin containing selection medium
for 4 to 5 weeks, Wnt4-expressing stable transfectants
were obtained.
The stable Wnt4-expressing C2C12 cells and parental
cells were cultured in either proliferation medium (PR)
containing 10% FBS in DMEM or in differentiation
medium (DF) consisting of 2% horse serum (Sigma-Al-
drich, St. Louis, MO, USA) in DMEM.
miRNA expression analysis
miRNA expression analysis was performed using total
RNA extracted from parental and Wnt4-expressing C2C12
cells under proliferation or differentiation conditions.
Total RNA was extracted from cultured cells using Iso-
gen (NIPPON GENE, Toyama, Japan) according to the
manufacturer’s instructions. Expression profiles were exam-
























Figure 5 MyoD expression in miRNA transfectants from day 1 to day 3 after transfection and medium change. The nuclear staining pattern is
shown (Green: Myo D, Blue: DAPI, photos were taken from the area indicated in the white rectangular). MyoD expression was observed in both
the cytoplasm and nucleus. Scale bar 50 μm. MyoD nuclear staining was counted and is presented in the bar graph. There were no significant
differences in MyoD nuclear positive ratios. NC: negative control.





















miR negative control miR-487b
miR-3963 miR-6412
Figure 6 The expression of myogenin in miRNA transfectants on day 3
after transfection. Expression of myogenin was observed in the cytoplasm
and nucleus. The nuclear staining pattern is shown (Green: myogenin,
Blue: DAPI, photos were taken from the area indicated in the white
rectangular). Nuclear myogenin expression was counted. There were
no significant differences in myogenin nuclear positive ratios. Scale bar
50 μm. NC: negative control.
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PR, and C2C12 in DF and Wnt4-expressing C2C12 in PR.
Labeling, hybridization, scanning, and data processing
were carried out with Toray 3D Gene (Toray, Tokyo, Japan).
Minimum information about a microarray experiment-
(MIAME-) compliant array data including raw data is de-
posited in the Gene Expression Omnibus (GEO) at NCBI
with accession number GSE63454.Transfection of miRNA
mirVana miR mimics used in this study were hsa-miR-206-
3p (assay ID: MC10409), hsa-miR-133a-3p (MC10413), hsa-
miR-133b-3p (MC10029), has-487b-3p (MC11296), mmu-
miR-3963 (MC20952) and mmu-miR-6412 (MC26271)
(Ambion, Life technologies). A scrambled miRNA, mirVana
miRNA mimic negative control and a miR-1 positive control
were used.C2C12 cells were cultured in 100-mm diameter dishes
until confluent, and transferred into 24-well plates in 2.5 ×
104 cells/ml/well. The next day, 16.5 pmol of miRNAs were
transfected using Lipofectamine RNAiMAX (Invitrogen,
Life Technologies) according to the manufacturer’s instruc-
tions. The next day, medium was changed to proliferation
medium or differentiation medium and maintained for
1 day to 1 week.
Reverse transcription quantitative polymerase chain
reaction (RT-qPCR)
The effect of miRNA transfection was determined by check-
ing the expression of the PTK9 gene (a target of miR-1)
using RT-qPCR [45]. The cells were harvested at 24 h, 48 h,
72 h and 1 week after medium change. Total RNA was ex-
tracted using Nucleospin RNA kits (MACHEREY-NAGEL
GmbH, Düren, Germany). RNA was reverse transcribed
into cDNA using ReverTra Ace (TOYOBO, Osaka, Japan)
and used for quantitative PCR analysis.
The quantitative RT-PCR was performed using THUN-
DERBIRD qPCR mix (TOYOBO) and Step One Plus (Ap-
plied Biosystems, Life Technologies). The PCR conditions
were 95°C for 1 min followed by 40 cycles of 95°C for 15 sec
and 60°C for 45 sec.
For quantification, standards were prepared by the fol-
lowing procedures. RPS29 was chosen as a housekeeping
gene [46], and the expression changes of PTK9 by the miR-
1 positive control were evaluated as PTK9/RPS29. The se-
quences of the primers used are indicated in Table 1.
Standards were prepared as follows. Real-Time PCR was
performed using the appropriate primers and the PCR
products were separated by electrophoresis in 2% agarose
gels. Then the bands were cut from the gel and amplicons
were extracted using a QIAGEN Gel Extraction Kit (QIA-
GEN, Valencia, CA, USA). The PCR products were cloned
with a pCRII-TOPO TA cloning kit (Life Technologies) into
DH5α cells. Colonies were picked and cultured in LB
medium, and plasmid DNA was extracted using a QiAprep
Spin Miniprep kit (QIAGEN). After confirming correct se-
quences, plasmid inserts were amplified by PCR using M13
primers and Takara LA-Taq (Takara, Shiga, Japan) accord-
ing to the manufacturer’s protocol. The PCR products were
extracted using a MinElute PCR Purification Kit (QIAGEN)
and then copy number was calculated. Finally, standards of
106 to 102 copies were prepared by serial dilution.
RT-qPCR for miRNA expression analysis
We performed quantitative PCR analysis to assess expres-
sion of miR-487b, miR-3963 and miR-6412. Total RNA
samples were collected from C2C12 cells cultured in prolif-
eration medium or differentiation medium. C2C12 cells
were seeded on 100-mm dishes at 2.0 × 106 cell/10 ml. The
next day, media were changed to proliferation medium
(DMEM containing 10% FBS) or differentiation medium
Table 1 Primer sequences used in this study
mouse RPS29 Forward 5′-ATG GGT CAC CAG CAG CTC TA -3′
Reverse 5′- AGC CTA TGT CCT TCG CGT ACT -3′
mouse PTK9 Forward 5′- GAG AGC GGA TGC TGT ATT CC -3′
Reverse 5′- CAG GAC CTT TCG GTT TAG CA -3′
M13 Forward 5′- GTA AAA CGA CGG CCA GT -3′
Reverse 5 - CAG GAA ACA GCT ATG AC -3′
miR-487b Forward 5′- AAG TGG ATG ACC CTG TAC GAT T - 3′
miR-3963 Forward 5′- TTG TGT CAG AAG TGG GAT ACA- 3′
miR-6412 Forward 5′- TAG TAG CTG AGG ATG GTT TCG A - 3′
miRNA Reverse 5′- GC GAG CAC AGA ATT AAT ACG AC -3′
Poly(T) Adaptor 5′- GCG AGC ACA GAA TTA ATA CGA CTC ACT ATA GGT TTT TTT TTT TTC G -3′
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3 days, and total RNA was extracted using ISOGEN (NIP-
PON GENE). cDNA synthesis and RT-qPCR was per-
formed using Universal cDNA synthesis kit II (EXIQON,
Woburn, MA, USA), ExiLENT SYBR® Green master mix
(EXIQON) and MicroRNA LNA™ PCR primer set (EXI-
QON), according to the manufacturer’s protocols.
We also designed primers for miR-487b, miR-3963 and
miR-6412 and performed quantitative PCR as reported
previously [47]. The forward primers were designed based
on the entire tested miRNA sequences, and the reverse
primer was designed based on the poly (T) adaptor se-
quence. The sequences of all primers and the poly(T)
adaptor are indicated in Table 1.
The cDNA was polyadenylated using a Poly(A) Tailing
kit according to the manufacturer’s instructions (Ambion,
Life technologies). After phenol-chloroform extraction and
ethanol precipitation, the RNA was dissolved in nuclease
free water, and reverse-transcribed using ReverTra Ace
(TOYOBO) with 0.5 μg of poly(T) adaptor. RPS29 was
selected as the internal reference gene for PCR quantifica-
tion. Real-time PCR was performed using THUNDER-
BIRD qPCR mix (TOYOBO) and Step One Plus (Applied
Biosystems, Life Technologies). The PCR conditions were
95°C for 10 min followed by 45 cycles of 95°C for 10 sec
and 60°C for 1 min. The quantity of miRNAs, relative to
the reference gene was calculated using the formula 2-ΔCt
(cycle threshold), where ΔCt = (Ct miRNA –Ct reference gene).
Comparison of miRNA expression was based on the ΔΔCt
method [48,49], and the relative miRNA expression can
be quantified according to the formula of 2-ΔΔCt, where
ΔΔCt = (ΔCt of C2C12 in DF) − (ΔCt of C2C12 in PR).Immunocytochemistry
After transfection of miRNAs, cells were fixed in 4% para-
formaldehyde for 10 min and rinsed with PBS three times.
Then cells were treated for 30 min with blocking buffer,
consisting of 3% BSA, 2% goat serum, 0.2% Tween 20 and0.1% NaN3 in PBS. Then, cells were incubated with anti-
troponin T (MAB1487, clone TT-98, Abnova, Taipei,
Taiwan), anti-fast myosin heavy chain (MyHC) (MY-23,
Sigma-Aldrich), anti-slow myosin heavy chain (NOQ7.5.4D,
Sigma-Aldrich), anti-myogenin (F5D, Santa Cruz, Dallas,
TX, USA) or anti-MyoD (C20, Santa Cruz) in blocking buf-
fer at 4°C overnight. The dilution of antibodies was 1:200,
1:400, 1:1000, 1:50 and 1:50, respectively. After three TBS
washes, cells were incubated with a 1:500 dilution of sec-
ondary Alexa Fluor 594-conjugated goat anti-rabbit or anti-
mouse IgG antibody (Life Technologies) for 1 h. After three
TBS washes, cell nuclei were stained with 1 μg/ml 4′,6′-
diamino-2-phenylindole solution (DAPI, DOJINDO, Kuma-
moto, Japan). Fluorescent images were taken using an All-
in-One Fluorescence Microscope BZ-9000 (Keyence Japan,
Osaka, Japan). Total cell number and troponin T, MyHC
(fast) or MyHC (slow), MyoD and myogenin-positive cells
were counted and the results are presented as positive cell
ratios. Approximately 1500-2000 cells/well in 6 wells were
counted in each independent experiment, and each experi-
ment was independently done more than three times to ob-
tain the statistically significant results.
Statistics
Significant differences between the control and the
miRNA groups were determined using Student’s t-test. All
computations were performed using PASW Statistics 18
(SPSS Inc., Chicago, IL, USA). P-value less than 0.05 was
considered to indicate a statistically significant result.
Additional files
Additional file 1: Figure S1. The efficacy of miRNA transfection was
assessed by real time quantitative RT-PCR. miR-1 positive control transfection
reduced its target gene (PTK9) expression significantly. RPS29 was used as a
control housekeeping gene.
Additional file 2: Figure S2. The expression of miR-487b, miR-3963 and
miR-6412 was assessed by RT-qPCR. The expression of these three miRNAs
was significantly down-regulated in C2C12 cells cultured in differentiation
medium, compared with cells cultured in proliferation medium.
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